Inventor
Hyori KIM
Inventor
KR
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
C12NMicroorganisms or enzymes12%
C12YEnzymes4%
PatentTitleYear
12,485,185Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereof202512,227,592Monoclonal antibody specifically binding to CCSP-2 and use thereof202512,098,206PDGF receptor antibody and use thereof202412,077,599Anti-ROS1 antibody and use thereof202411,707,486Natural killer cell expressing anti-cotinine chimeric antigen receptor202311,478,555Chimeric antigen receptor to which anti-cotinine antibody is linked, and use thereof202211,339,210Anti-C5 antibodies and methods of treating complement-related diseases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to SEOUL NAT UNIV R&DB FOUNDATION (6)· patent assignee history
2022–2025Based in KR· patent location history
2024–2025Patents assigned to ASAN FOUND (2)· patent assignee history
2024–2025Patents assigned to UNIV ULSAN FOUND IND COOP (2)· patent assignee history
2024Patents assigned to EWHA UNIVERSITY—INDUSTRY COLLABORATION FOUND (1)· patent assignee history
2025Patents assigned to EDISBIOTECH CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEOUL NAT UNIV R&DB FOUNDATION | 6 | 2022–2025 |
| ASAN FOUND | 2 | 2024–2025 |
| UNIV ULSAN FOUND IND COOP | 2 | 2024–2025 |
| EDISBIOTECH CO LTD | 1 | 2025 |
| EWHA UNIVERSITY—INDUSTRY COLLABORATION FOUND | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| KR | 7 | 2022–2025 |